Validation and Verification of Analytical Testing Methods Used for Tobacco Products; Guidance for Industry; Availability
Published Date: 1/7/2025
Notice
Summary
The FDA just released final guidance to help tobacco companies make sure their testing methods for ingredients and product stability are accurate and reliable. This means better, more consistent data when companies submit info about their tobacco products. If you’re in the tobacco biz, get ready to follow these updated testing rules starting now—no extra fees, just clearer standards!
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Final Guidance on Lab Test Methods
On January 7, 2025, FDA issued final guidance titled "Validation and Verification of Analytical Testing Methods Used for Tobacco Products" to help tobacco product manufacturers and testing labs produce more consistent and reliable analytical data for regulatory submissions such as SE reports, PMTAs, and MRTPAs. The guidance finalizes the December 22, 2021 draft and explains recommended validation and verification practices for ingredients, constituents, additives, stability testing, and HPHC reporting.
Guidance Covers Synthetic Nicotine Products
The final guidance updates the Background section to reflect that the statutory term "tobacco product" now includes non-tobacco (synthetic) nicotine as a result of Pub. L. 117-103. That means the guidance's validation and verification recommendations apply to products containing synthetic nicotine as well as traditional tobacco products.
Lab Accreditation Documentation Updated
The final guidance includes updates reflecting PMTA and SE Report rule requirements for documenting laboratory accreditation. Applicants submitting PMTAs or SE reports should follow the updated recommendations for how to document laboratory accreditation in support of analytical testing data.
New Flexibility in Validation Approaches
FDA's final guidance acknowledges that alternative validation procedures may differ from the guidance and adds technical options such as a spike-and-recovery approach to determine limit of detection and an equation to adjust for interference bias when determining selectivity. The guidance also clarifies the Agency's view on using linear regression (R2) for linearity.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-20724, Notice of Intent To Prepare a Supplemental Environmental Impact Statement for the Sentinel Deployment and Minuteman III Decommissioning and Disposal
The Air Force is updating its plan to replace old Minuteman III missiles with new Sentinel missiles across five states, including Wyoming, Montana, and North Dakota. They’re checking how these changes might affect the environment and want your thoughts during a 30-day comment period starting now. This update could impact local lands and communities, with careful reviews to keep things safe and smart.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20708, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Amend the IEX Equities Fee Schedule
IEX is shaking up its fee schedule starting November 1, 2026, by tweaking who gets rebates for adding displayed liquidity and changing rebate amounts. This affects IEX members who trade stocks, giving them new ways to save or earn more on fees. The changes kick in right away after filing, so traders should get ready to adjust their strategies and cash flow.
2026-20710, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Modify the Required Criteria To Qualify for the Reduced Incremental Fee
Investors Exchange (IEX) is changing the rules for who can get a discount on certain trading fees. Starting November 1, 2026, members will need to meet new criteria to qualify for the reduced incremental fee, which could save or cost them money depending on their trading activity. This change affects all IEX members and kicks in right away to keep things fair and clear.
2026-20779, Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce found that tires from Thailand were sold in the U.S. for less than their normal price between July 2024 and June 2025. This means some importers might have to pay extra duties to keep things fair. The review process had some delays due to government shutdowns, but now the preliminary results are out and open for comments.
2026-20763, National Environmental Policy Act Implementing Procedures: Wintertime Oil and Gas Exploration in the National Petroleum Reserve in Alaska Categorical Exclusion
Starting October 9, 2026, the Department of the Interior is making it easier and faster to approve wintertime oil and gas exploration in Alaska’s National Petroleum Reserve by adding a special rule that skips some usual paperwork. This change mainly affects energy companies working in the area and aims to speed up projects while still protecting the environment. No new costs are expected, but the process will be smoother and quicker.
Previous / Next Documents
Previous: 2024-31540, Pulse Oximeters for Medical Purposes-Non-Clinical and Clinical Performance Testing, Labeling, and Premarket Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is sharing draft rules to make sure pulse oximeters—those handy devices that check your blood oxygen and pulse—work well for everyone, no matter skin color. These new guidelines suggest how to test, label, and submit these devices for approval, aiming for safer and more accurate readings. Companies making these devices should check out the draft and send feedback by March 10, 2025, to help shape the final rules.
Next: 2024-31542, Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Comment Request
The FDA is rolling out a draft guide to help drug and biological product makers use artificial intelligence (AI) safely and smartly when making decisions about their products. This affects companies working on medicines and biologics, aiming to boost safety and quality without slowing things down. Comments on this guide are open until April 7, 2025, so industry folks have time to weigh in before the final rules drop.